Skip to content
Clinical ResearchResearch compoundModerate evidence

Hyperforin

The main antidepressant constituent of St. John's Wort; activates TRPC6 to indirectly inhibit monoamine reuptake.

AntidepressantHerbAntidepressantMoodSerotoninDopamineNorepinephrine

Pharmacology

ClassAntidepressant · Mood
Primary targetTRPC6 channel activation, sodium influx
Targets4 receptor targets
Half-lifeApproximately 9-12 hours
OnsetAs a standardized extract with meals, typically three times daily; mood effects build over weeks
EvidenceModerate evidence
Affected systemsSerotoninDopamineNorepinephrine

Contents

WHAT IS HYPERFORIN?

Detailed overview

Hyperforin is a lipophilic phloroglucinol and one of the main active constituents of St. John's Wort (Hypericum perforatum), regarded as a key carrier of the plant's antidepressant activity. Unlike classic SSRIs it does not block transporters directly; instead it activates the TRPC6 cation channel, and the resulting sodium (and calcium) influx raises intracellular sodium, which lowers the driving force for reuptake of serotonin, dopamine and norepinephrine. It also promotes neurite outgrowth and BDNF signaling, but as a strong PXR agonist it induces the CYP3A4 enzyme, creating a significant drug-interaction risk. Most evidence for the isolated compound is preclinical and mechanistic, while clinical antidepressant efficacy has mainly been shown for standardized St. John's Wort extracts that contain hyperforin.

Mechanism

TRPC6 activation, indirect monoamine reuptake inhibition

Half-life

Approximately 9-12 hours

Legal status

Herbal constituent (in St. John's Wort extract)

Receptor profile

  • TRPC6 channel / sodium influxStrong
  • Monoamine reuptake (serotonin/dopamine/norepinephrine)Moderate
  • Pregnane X receptor (CYP3A4 induction)Strong
  • BDNFWeak

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Photosensitivity (phototoxic skin reactions), especially in fair-skinned people and strong sunlight
  • Mild gastrointestinal upset, nausea, appetite changes
  • Restlessness, sleep changes and headache
  • Risk of serotonin syndrome when combined with other serotonergic drugs
  • Major drug interactions due to CYP3A4 and P-glycoprotein induction
  • Dry mouth, dizziness, occasionally skin itching

Contraindications · 5

  • Concurrent SSRI, SNRI, MAO inhibitor or triptan therapy: risk of serotonin syndrome
  • Pregnancy and breastfeeding: safety not well established, avoid
  • Patients on critical medications (contraceptives, warfarin, ciclosporin/tacrolimus, antiretroviral and anticancer drugs): enzyme induction can cause loss of efficacy
  • Before planned surgery or anesthesia: enzyme induction can alter drug metabolism
  • Known photosensitivity or concurrent photosensitizing therapy

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

The main antidepressant constituent of St. John's Wort; activates TRPC6 to indirectly inhibit monoamine reuptake.

Telegram

Have a question about Hyperforin?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeAntidepressant
FormulaC35H52O4
UpdatedJuly 10, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: July 10, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.